Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Apellis Pharmaceuticals (APLS)
Technical Analysis Report for NASDAQ stock APLS Apellis Pharmaceuticals. Dated: 23 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock APLS Apellis Pharmaceuticals then click here. or read Experts views on Apellis Pharmaceuticals or Forecast & share price targets of Apellis Pharmaceuticals
Apellis Pharmaceuticals Opened at 17.60 and Closed at: 17.57, which is 2.11% of previous session's close. It moved within a range of 17.32 and 17.94
The session was a Bearish session with an average volume of 2408400, which is 31.57% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 17.14 and resistance for tomorrow is 17.76
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 17.28, 16.99 resistance for tomorrow's hourly charts is 17.9, 18.23
10 Day SMA for Apellis Pharmaceuticals (APLS) is 18.68 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Apellis Pharmaceuticals (APLS) is 19.82 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Apellis Pharmaceuticals (APLS) is 21.28 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 22.07 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Apellis Pharmaceuticals is 22.52 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Apellis Pharmaceuticals is at 19.82 and 200 DMA is at 22.52, while 50 DMA and 100 DMA are at 21.28 and 22.07 respectively
Apellis Pharmaceuticals (APLS) moving average of 20 SMA is at 19.82 and 20 EMA is at 19.52
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Mon Mar | 17.57 | 19.82 | 19.52 |
| 20 Fri Mar | 17.20 | 20.05 | 19.72 |
| 19 Thu Mar | 17.97 | 20.33 | 19.99 |
| 17 Tue Mar | 18.82 | 20.54 | 20.2 |
| 16 Mon Mar | 18.87 | 20.68 | 20.35 |
| 13 Fri Mar | 18.94 | 20.82 | 20.51 |
Apellis Pharmaceuticals (APLS) moving average of 50 SMA is at 21.28 and 50 EMA is at 20.97
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Mon Mar | 17.57 | 21.28 | 20.97 |
| 20 Fri Mar | 17.20 | 21.45 | 21.11 |
| 19 Thu Mar | 17.97 | 21.64 | 21.27 |
| 17 Tue Mar | 18.82 | 21.76 | 21.4 |
| 16 Mon Mar | 18.87 | 21.88 | 21.51 |
| 13 Fri Mar | 18.94 | 22.02 | 21.62 |
Apellis Pharmaceuticals (APLS) moving average of 100 SMA is at 22.07 and 100 EMA is at 21.88
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Mon Mar | 17.57 | 22.07 | 21.88 |
| 20 Fri Mar | 17.20 | 22.19 | 21.97 |
| 19 Thu Mar | 17.97 | 22.3 | 22.07 |
| 17 Tue Mar | 18.82 | 22.41 | 22.15 |
| 16 Mon Mar | 18.87 | 22.5 | 22.22 |
| 13 Fri Mar | 18.94 | 22.6 | 22.29 |
Apellis Pharmaceuticals (APLS) moving average of 200 SMA is at 22.52 and 200 EMA is at 23.11
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Mon Mar | 17.57 | 22.52 | 23.11 |
| 20 Fri Mar | 17.20 | 22.53 | 23.17 |
| 19 Thu Mar | 17.97 | 22.54 | 23.23 |
| 17 Tue Mar | 18.82 | 22.53 | 23.28 |
| 16 Mon Mar | 18.87 | 22.52 | 23.33 |
| 13 Fri Mar | 18.94 | 22.51 | 23.37 |
Zai Lab has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Zai Lab, about 11.11% more returns!
Trupanion Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Trupanion Inc, about 18.5% more returns!
Soligenix Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Soligenix Inc, about 31.81% more returns!
Ultragenyx Pharmaceutical has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 11.86% more returns!
Ptc Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 16.02% more returns!
Pro Dex has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Pro Dex, about 40.59% more returns!
Puma Biotechnology has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Puma Biotechnology, about 9.71% more returns!
Ocular Therapeutix has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Ocular Therapeutix, about 18.12% more returns!
Nektar Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 22.79% more returns!
Atyr Pharma has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Atyr Pharma, about 13.9% more returns!
Achieve Life has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Achieve Life, about 17.78% more returns!
Atricure Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 15.49% more returns!
Axsome Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 11.56% more returns!
Biogen Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Biogen Inc, about 15.34% more returns!
Caredx Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 15.26% more returns!
Diamedica Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Diamedica Therapeutics, about 9.54% more returns!
Exelixis Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Exelixis Inc, about 15.9% more returns!
Eyegate Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 19.34% more returns!
Iradimed Corporation has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Iradimed Corporation, about 20% more returns!
Apellis Pharmaceuticals Technical analysis of indicators
Price action analysis of Apellis Pharmaceuticals (APLS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Apellis Pharmaceuticals in short term and the sell signal is strong.
Apellis Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Apellis Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Apellis Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 18.6 and Apellis Pharmaceuticals APLS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Apellis Pharmaceuticals APLS stock. Volume based technical analysis of Apellis Pharmaceuticals APLS stock is negative.
Apellis Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock APLS Apellis Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And APLS Experts View which covers a lot of information including buying and selling signals
APLS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Apellis Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


